tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Similar Stocks

99 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
MiNK Therapeutics
$38.89M
-1.88
-40.74%
2 Buy
0 Hold
0 Sell
Moderate Buy
BioNTech SE
$20.19B
165.21
-20.76%
5 Buy
7 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$4.88B
-21.11
-1.31%
9 Buy
6 Hold
1 Sell
Moderate Buy
Editas Medicine
$461.36M
-2.67
-34.69%
3 Buy
7 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$2.51B
-4.85
-41.06%
15 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
INKT
MiNK Therapeutics
1.14
-0.75
-39.68%
BNTX
BioNTech SE
84.25
-23.90
-22.10%
CRSP
Crispr Therapeutics AG
57.46
-0.29
-0.50%
EDIT
Editas Medicine
5.61
-3.11
-35.67%
NTLA
Intellia Therapeutics
26.01
-18.17
-41.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis